Recall: Lyrica for Nerve Pain and Seizures

Roni Shye
Roni Shye, PharmD BCGP BCACP, is a licensed pharmacist in the states of Florida, Ohio, and Pennsylvania.
Posted on

Manufacturer Pfizer has issued a voluntary recall of two strengths of Lyrica (pregabalin). Lyrica is a popular medication used to help relieve nerve pain, and in combination with other medications for some kinds of seizures.

This is a class II recall, the most common type of recall, which means that there is a situation where use of the recalled medication may cause temporary or medically reversible adverse health consequences, but the likelihood of serious adverse effects is small. For more information on the different types of recalls, see our overview here.

Who can recall a drug?

A manufacturer can voluntarily recall their medication, or the Food and Drug Administration (FDA) can request or require that a manufacturer recall a particular medication. In this case, the manufacturer has voluntarily recalled three lots of Lyrica 50 mg and 75 mg capsules.

Why has Lyrica been recalled?

The recall was initiated because some Lyrica capsules in the affected lots may be deformed or damaged. This can affect the integrity of the medication in those capsules, which means they could lose some of the active ingredient—so you may or may not be getting the full dose with each capsule. If you don’t receive the correct dose, your prescription may not be as effective.

When was the recall initiated?

The affected lots of Lyrica were recalled by the manufacturer on January 14, 2016. These lots started shipping in September 2015, so if you have leftover medication from before that date, yours would not be affected.

Are patients who have taken this medication being notified?

No. This is a class II recall, which means that it isn’t necessary to notify you unless your doctor believes it may have an effect on your health.

If you have concerns that your prescription may be affected, contact your doctor or your pharmacist.

Which products were affected?

In this recall, three lots and two strengths of Lyrica are affected.

Drug: Lyrica 50 mg capsule, 90-count bottle
Manufacturer: Pfizer
Lot: M07861, expiration 5/31/2018
National Drug Code (NDC): 00071-1013-68

Drug: Lyrica 75 mg capsule, 90-count bottle
Manufacturer: Pfizer
Lots: M07862 and M07865, expiration 5/31/2018 and 6/30/2018
National Drug Code (NDC): 00071-1014-68

If you have any trouble finding the lot and NDC information on your prescription, please check with your pharmacist for more information.

Drugs featured in this story

Filed under